FREDUN PHARMACEUTICALS
|
FREDUN PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| Profit Before Tax | ₹35 Cr | ₹27 Cr |
| Adjustment | ₹46 Cr | ₹28 Cr |
| Changes In working Capital | ₹-69 Cr | ₹-72 Cr |
| Cash Flow after changes in Working Capital | ₹12 Cr | ₹-17 Cr |
| Cash Flow from Operating Activities | ₹12 Cr | ₹-17 Cr |
| Cash Flow from Investing Activities | ₹-74 Cr | ₹-6.35 Cr |
| Cash Flow from Financing Activities | ₹121 Cr | ₹27 Cr |
| Net Cash Inflow / Outflow | ₹60 Cr | ₹3.70 Cr |
| Opening Cash & Cash Equivalents | ₹5.22 Cr | ₹1.52 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹65 Cr | ₹5.22 Cr |
Compare Cashflow Statement of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹2,613.0 Cr | 3.7% | 3.4% | 189% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 3.7% |
3.4% |
189% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses